Study
|
Patient
|
Comorbidities
|
Symptoms
|
Complications
|
Labs
|
Treatment
|
Outcome
|
Mahmood et al. 2021 [2]
|
27, F
|
None
|
Abdominal pain
|
Possible splenic hemorrhage
|
D-dimer peak at >20 µg/mL
|
Prophylactic heparin 5,000 U sq TID daily transitioned to LMWH
|
Discharged on apixaban
|
de Roquetaillade et al. 2021 [5]
|
Three patients
|
Not reported besides 1 with PFO
|
Not reported
|
Not reported
|
Not reported
|
Not reported
|
Not reported
|
Dennison et al. 2021 [7]
|
70, M
|
HTN
|
Left lower quadrant abdominal pain
|
Bilateral rectus sheath hematomas, mesenteric vessel microhemorrhage
|
D-dimer 3.90 mg/mL
|
Prophylactic enoxaparin transitioned to LMWH 80 mg BID
|
Discharged
|
Santos et al. 2020 [11]
|
67, M
|
HTN
|
Asymptomatic
|
Pulmonary PE
|
Not reported
|
Not reported
|
Not reported
|
53, F
|
None
|
Asymptomatic
|
None
|
Not reported
|
Not reported
|
Not reported
|
Qasim et al. 2020 [12]
|
60s, M
|
Asthma, OSA, morbid obesity, HTN, IgG deficiency
|
Dull left-sided abdominal pain
|
None
|
D dimer 1,088 ng/mL, ferritin 3,038 ng/mL
|
Prophylactic enoxaparin 40 mg BID transitioned to heparin drip for 24 hours, followed by enoxaparin 1 mg/kg BID
|
Discharged on rivaroxaban
|
Ramanathan et al. 2021 [13]
|
54, M
|
Obese
|
Sharp abdominal pain, nausea, vomiting
|
Kidney infarction
|
D-dimer 1.55 µg/mL, ferritin 1,633 ng/mL, LDH 2,136 U/L
|
Heparin drip at 18 U/kg/hour
|
Discharged on apixaban
|
Imoto et al. 2021 [14]
|
54, M
|
Not reported
|
Asymptomatic within GI
|
Multiple cerebral infarcts, bilateral renal infarcts
|
Not reported
|
Lovenox
|
Expired
|
Besutti et al. 2020 [15]
|
53, M
|
HTN, previous mitral valve replacement
|
Severe left flank pain
|
Left kidney infarct
|
Not reported
|
LWWH 6,000 U BID for 2 days
|
Discharged
|
72, M
|
HTN, DM type 2, CKD stage 3, CAD
|
Severe abdominal pain
|
Small bowel ischemia
|
D-dimer 6,910 ng/mL
|
LMWH 4,000 U/day along with acetylsalicylic acid, resection of ischemic bowel, splenectomy, transitioned to heparin drip
|
Not reported
|
Sztajnbok et al. 2021 [16]
|
60, F
|
None
|
Asymptomatic
|
Aortic thrombosis of descending aorta
|
D-dimer 4,057 ng/mL, ferritin 719 ng/mL
|
Prophylactic LMWH 60 mg/day, transitioned to LMWH 60 mg BID
|
Discharged on warfarin
|
Hossri et al. 2020 [17]
|
29, F
|
Sickle cell disease
|
Abdominal pain, vomiting
|
Ischemic stroke
|
D-dimer 2,822 ng/mL, ferritin 4,511 ng/mL
|
Heparin drip
|
Not reported
|
Karki et al. 2020 [18]
|
32, M
|
None
|
Severe periumbilical pain
|
Splenic laceration with hemoperitoneum
|
Not reported
|
Supportive care
|
Not reported
|
Bradley et al. 2021 [19]
|
76, F
|
HLD
|
Not reported
|
Subarachnoid hemorrhages, pulmonary thrombus, myocarditis
|
Not reported
|
Not reported
|
Expired
|
Tranca et al. 2021 [20]
|
31, F
|
None
|
Mild dull abdominal pain
|
Not reported
|
Not reported
|
Enoxaparin 1 mg/kg BID, aspirin
|
Not reported
|
Rigual et al. 2021 [21]
|
53, M
|
Not reported
|
Not reported
|
Ischemic stroke, hemorrhagic splenic infarct, bilateral renal infarction, splenic pseudoaneurysm
|
Not reported
|
IV thrombolysis and mechanical thrombectomy, followed by enoxaparin 1 mg/kg daily, acetylsalicylic acid 100 mg
|
Discharged on acetylsalicylic acid
|
Ghalib et al. 2021 [22]
|
67, F
|
HTN, DM, CAD, asthma
|
Asymptomatic
|
None
|
D-dimer 1,072 ng/mL, ferritin 536 ug/L, CRP 163.3 mg/L
|
Therapeutic heparin infusion
|
Discharged on LMWH
|
Vidali et al. 2021 [23]
|
70, F
|
Not reported
|
Left upper quadrant pain
|
Thrombosis of extrahepatic and intrahepatic portal branches, thrombosis of splenic and mesenteric veins
|
CRP 10.8 mg/dL, LDH 248 U/L, D-dimer 4,926 ng/mL
|
LMWH 8,000 U
|
Not reported
|
Moradi et al. 2021 [24]
|
59, F
|
DM, HTN, HLD
|
Left upper quadrant pain, left flank pain
|
Limb ischemia
|
Normal D-dimer
|
Heparin drip
|
Discharged on rivaroxaban, aspirin, clopidogrel
|
Ceci et al. 2021 [25]
|
47, M
|
HLD, DM
|
Acute abdominal pain
|
ACS, myocarditis, kidney infarction
|
Not reported
|
Aspirin, clopidogrel, enoxaparin 1 mg/kg BID, then transitioned to unfractionated heparin drip; transitioned to warfarin; transitioned to enoxaparin 1 mg/kg BID
|
Discharged on warfarin
|
Abdelmohsen et al. 2021 [26]
|
Three patients
|
Not reported
|
Not reported
|
One had small bowel infarcts
|
Not reported
|
Not reported
|
Not reported
|
Mavraganis et al. 2022 [27]
|
64, M
|
None
|
Severe abdominal pain
|
Renal thrombosis, splenic vein thrombosis, thoracic aorta thrombi, renal infarct
|
LDH 1,244 U/L, D-dimer 3.7 mg/L, CRP 1.7 mg/dL
|
LMWH 6,000 U daily, then transitioned to enoxaparin 8,000 U BID with acetylsalicylic acid 80 mg daily, transitioned to fondaparinux sq 7.5 mg
|
Discharged on acetylsalicylic acid 80 mg and fondaparinux 7.5 mg sq
|
Berrichi et al. 2021 [28]
|
45, M
|
None
|
Acute abdominal pain in the left upper quadrant
|
Acute limb ischemia, renal infarcts, thrombosis of splenic vein
|
Not reported
|
IV unfractionated heparin 80 U/kg, thrombectomy, followed by unfractionated heparin drip at 18 U/kg/hour
|
Discharged
|
Javaid et al. 2022 [29]
|
44, M
|
HTN, obesity
|
Severe abdominal pain
|
None
|
Not reported
|
Supportive
|
Discharged
|
Rea et al. 2021 [30]
|
Three patients
|
Not reported
|
Not reported
|
Not reported
|
Not reported
|
Not reported
|
Not reported
|
Guillet et al. 2020 [31]
|
57, M
|
DM, obesity
|
Not reported
|
Mesenteric thrombi, renal infarction, lower limbs ischemia
|
D-dimer 1,169 µg/L, CRP 139 mg/L
|
Prophylactic LMWH transitioned to low-dose acetylsalicylic acid and IV unfractionated heparin
|
Discharged on warfarin
|